Re: $14 Billion Pfizer Buyout Worth About $85/share.
Sorry to hear you weren't there till the proverbial end,
but sounds like you made plenty. I was getting fidgety
on this one as well, but luckily exercised patience enough
to let the end game play itself out.
Don't know WHAT Biomarin was thinking when they sold Talazoparib
to Medivation. Ironic how they kept drisapersin (for Duchenne's),
which they bought from Prosensa, and it ended up being a failure
Guess Biomarin is now the next one in play - with Sanofi and Roche
being prominent mentions. Call options went crazy on that one
today. No telling what other bidders there might be in addition.
FYI - Sold all my shares of MDVN today.
Good luck to all.